“I repeat that 2012 will be approved before your bull case and years before your base case. The recent clinical trials update for AML posts primary completion by year end. You are the one speculating.”
and Heart was going to be commercialized in 2020. You are so out of your depth it is embarrassing.
You said we were going to get data on 2012 during August’s earnings… where was it?
I said we would not see a data readout on the 15 phase 1 patients until November at this earliest. You should have sent me a DM to understand my reasoning like others did. Although I might have not responded.